Cross-condition Validation of the Steroid PRO
Conditions: Inflammatory Disease; Immune System Disorder; Gastrointestinal Diseases; Dermatologic Disease; Respiratory Disease Interventions: Other: Cognitive Interview Sponsors: University of the West of England; Johns Hopkins University; University of Pittsburgh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
The Effect of the Helper Skin Tap Technique and Buzzy ® During Vaccination
Conditions: Child, Only Interventions: Other: Helfer Skin Tap; Other: Buzzy Sponsors: Tarsus University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
National Register of Moderate and Severe Adult Atopic Dermatitis
Conditions: Atopic Dermatitis Sponsors: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma Sponsors: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Assessment of Anti-aging Efficacy of Marine Collagen Peptides
Conditions: Skin Condition; Hair Fragility; Nails, Ingrown Interventions: Dietary Supplement: Marine Collagen Peptides; Dietary Supplement: placebo drink Sponsors: TCI Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda ® in Patients With Malignant Neoplasms
Conditions: Skin Melanoma; Squamous Non-small-cell Lung Cancer; Head and Neck Squamous Cell Carcinoma Interventions: Drug: RPH-075; Drug: Keytruda ® Sponsors: R-Pharm; Data Management 365; Exacte Labs LLC; Federal State Budgetary Institution " NMIC of Hematology " of the Ministry of Health of the Russian Federation; Federal State Budgetary Institution of the Central Research Institute of Epidemiology of Rospotrebnadzor Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
The Efficacy of a Cosmetic Preparation Containing Sheep Colostrum on Mature Skin
Conditions: Skin Aging Interventions: Other: colostrum cream; Other: placebo cream Sponsors: Medical University of Lodz Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
Conditions: Tuberculosis Interventions: Biological: 2.5 μg/ml EEC; Biological: 5μg/ml EEC; Biological: 5 unit（U） EC Sponsors: Chengdu CoenBiotech Co., Ltd; Beijing Chest Hospital, Capital Medical University; Wuhan Institute for Tuberculosis Control; The Public Health Clinical Center of Chengdu; Xuzhou Infectious Disease Hospital; Jiangsu Province Centers for Disease Control and Prevention; Changde First People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Protocol for a Diagnostic Test Accuracy of Histological Muscle and Skin Biopsies of Rheumatoid Arthritis Patients Revealing Objective Chronic Widespread Pain Phenomena Related to Fibromyalgia
Conditions: Rheumatoid Arthritis; Fibromyalgia, Secondary; Widespread Chronic Pain; Muscle Disorder Interventions: Diagnostic Test: Muscle- and skin biopsies Sponsors: Hospital of South West Jutland; Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
More Than Two-Thirds of People with Atopic Dermatitis and Skin of Color Experienced Skin Improvement in a First-of-its-Kind Lebrikizumab Study
INDIANAPOLIS, March 10, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color and moderate-to-severe atopic dermatitis, commonly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 10, 2024 Category: Pharmaceuticals Source Type: clinical trials
New Data Shows JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-to-Severe Plaque Psoriasis Through One Year
SAN DIEGO (March 9, 2024)– Johnson& Johnson today announced the first data from FRONTIER 2, the long-term extension of the Phase 2b FRONTIER 1 clinical trial evaluating JNJ-2113, the first and only investigational targeted oral peptide... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 9, 2024 Category: Pharmaceuticals Source Type: clinical trials
A Herbal Compound for Psoriasis
Conditions: Psoriasis; Inflammation; Skin Diseases Interventions: Dietary Supplement: ZAX.1400.P03; Drug: Placebo Sponsors: Fasa University of Medical Sciences; Zarrin Avaye Kowsar Salamat (ZAX company) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]
Conditions: Melanoma, Skin; Melanoma Stage Iii Interventions: Diagnostic Test: Gut microbiota analysis Sponsors: Russian Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Effect of Vitamin D Injection on Hypertrophic Scars and Keloids
Conditions: Dermatologic Disease Interventions: Drug: Cholecalciferol Sponsors: Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
Conditions: Atopic Dermatitis; Food Allergy; Healthy Interventions: Other: Data and biospecimen collection; Other: Skin biopsies; Other: Oral Food Challenge (OFC) procedures Sponsors: University of Michigan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
